By Frank Prenesti
Date: Monday 27 Jan 2020
(Sharecast News) - AstraZeneca said it had agreed to sell the global commercial rights to a range of hypertension treatments to Atnahs Pharma for up to $390m.
By Abigail Townsend
Date: Tuesday 05 Nov 2019
(Sharecast News) - Botox maker Allergan, which is being taken over in a $63bn blockbuster deal, has upped its full-year guidance after posting a forecast-beating set of third-quarter numbers.
By Iain Gilbert
Date: Tuesday 25 Jun 2019
(Sharecast News) - Chicago-based biopharmaceutical company Abbvie snapped up Botox-maker Allergan for roughly $63bn on Tuesday, mostly in cash.
Currency | US Dollars |
Share Price | $ 166.42 |
Change Today | $ 2.07 |
% Change | 1.26 % |
52 Week High | $182.10 |
52 Week Low | $132.51 |
Volume | 5,152,176 |
Shares Issued | 1,765.94m |
Market Cap | $293,888m |
RiskGrade | 122 |
Strong Buy | 4 |
Buy | 13 |
Neutral | 10 |
Sell | 0 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
15:59 | 100 @ $166.48 |
15:59 | 100 @ $166.48 |
15:59 | 100 @ $166.41 |
15:59 | 100 @ $166.42 |
15:59 | 100 @ $166.42 |
You are here: research